Clinical Trials Directory

Trials / Completed

CompletedNCT02726516

Effects of PRJ-205 on Performance in Trained Young Subjects

Effects of PRJ-205 on Performance in Trained Young Subjects After Acute and Chronic Intake of the Study Product

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Bioiberica · Industry
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Compare a dietary supplement (PRJ-205) and placebo during 1 or 4 days on aerobic exercise performance, oxidative stress and muscle damage. The hypothesis is that supplementation with PRJ-205 improve aerobic performance

Detailed description

Twenty young active males will be recruited and randomized to either placebo or PRJ-205. Subjects will take the designated treatment in an acute dosage and chronically, 4 days of treatment. They will undergo 3 exercise tasks (before the administration of the product, 1.5h after the acute administration of the product and after 4 days of treatment). VO2max and anaerobic threshold will be measured during the tests. Blood samples will be taken to measure muscle damage and oxidative stress.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPRJ-2051 sachet per day
OTHERPlacebo1 sachet per day

Timeline

Start date
2016-03-01
Primary completion
2016-04-01
Completion
2016-06-01
First posted
2016-04-01
Last updated
2016-12-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02726516. Inclusion in this directory is not an endorsement.